FDA Reglan Tardive Dyskinesia Warning More than a Year Old
The U.S. Food and Drug Administration (FDA) has implemented a black box warning for Reglan and all other drugs containing metoclopramide. According to a news report, what is curious about the recent buzz surrounding the Reglan black box warning is that it is more than a year old. The FDA news release dated February 26, 2009 talks about the Reglan black box warning. There are no recent releases or warnings that relate to Reglan.
The FDA warning stated that one of the effects of the drug, used to treat gastroesophageal reflux disease or diabetic gastroparesis, is "tardive dyskinesia," or involuntary movement disorders. The black box warning, which is the most serious warning that can be issued by the FDA, also states that these side effects can be irreversible with no known cure available.
Another analysis of study data by the FDA showed that about 20 percent of patients in that study who used Reglan took it for more than three months. Also, the FDA is continuing to receive more reports of tardive dyskinesia in patients who used or continued to use Reglan. Tardive dyskinesia is characterized by involuntary movement of facial muscles, the tongue, the eyes, fingers and other extremities. An individual of any age is at risk for drug-induced tardive dyskinesia.
If you are taking Reglan or any generic forms of the drug and have experienced any of these symptoms, contact your doctor immediately. You would also be well-advised to contact a knowledgeable St. Louis drug injury lawyer from Page Law to learn about your rights and potential legal options. Call our skilled Missouri personal injury and products liability attorneys today at 866-620-5757 for a free consultation.
Source: http://www.lawyersandsettlements.com/articles/13803/reglan-side-effects-tardive-dyskinesia-36.html
